1. Short and long-term outcomes of percutaneous left atrial appendage suture ligation: Results from a US multicenter evaluation.
- Author
-
Lakkireddy D, Afzal MR, Lee RJ, Nagaraj H, Tschopp D, Gidney B, Ellis C, Altman E, Lee B, Kar S, Bhadwar N, Sanchez M, Gadiyaram V, Evonich R, Rasekh A, Cheng J, Cuoco F, Chandhok S, Gunda S, Reddy M, Atkins D, Bommana S, Cuculich P, Gibson D, Nath J, Ferrell R, Matthew E, and Wilber D
- Subjects
- Aged, Atrial Fibrillation mortality, Female, Humans, Ligation adverse effects, Ligation methods, Male, Middle Aged, Outcome and Process Assessment, Health Care, Punctures instrumentation, Punctures methods, Registries statistics & numerical data, United States epidemiology, Atrial Appendage surgery, Atrial Fibrillation surgery, Cardiovascular Surgical Procedures adverse effects, Cardiovascular Surgical Procedures instrumentation, Cardiovascular Surgical Procedures methods, Heart Injuries epidemiology, Heart Injuries etiology, Heart Injuries prevention & control, Intraoperative Complications epidemiology, Intraoperative Complications etiology, Intraoperative Complications prevention & control, Long Term Adverse Effects epidemiology, Pericarditis epidemiology, Pericarditis etiology, Postoperative Complications epidemiology
- Abstract
Background: Published studies of epicardial ligation of left atrial appendage (LAA) have reported discordant results., Objective: The purpose of this study was to delineate the safety and efficacy of LAA closure with the LARIAT device., Methods: This is a multicenter registry of 712 consecutive patients undergoing LAA ligation with LARIAT at 18 US hospitals. The primary end point was successful suture deployment, no leak by intraprocedural transesophageal echocardiography (TEE), and no major complication (death, stroke, cardiac perforation, and bleeding requiring transfusion) at discharge. A leak of 2-5 mm on follow-up TEE was the secondary end point., Results: LARIAT was successfully deployed in 682 patients (95.5%). A complete closure was achieved in 669 patients (98%), while 13 patients (1.8%) had a trace leak (<2 mm). There was 1 death related to the procedure. Ten patients (1.44%) had cardiac perforation necessitating open heart surgery, while another 14 (2.01%) did not need surgery. The risk of cardiac perforation decreased significantly after the introduction of a micropuncture (MP) needle for pericardial access. Delayed complications (pericarditis requiring >2 weeks of treatment with nonsteroidal anti-inflammatory drugs/colchicine and pericardial and pleural effusion after discharge) occurred in 34 (4.78%) patients, and the risk decreased significantly with the periprocedural use of colchicine. Follow-up TEE (n = 480) showed a leak of 2-5 mm in 6.5% and a thrombus in 2.5%. One patient had a leak of >5 mm., Conclusion: LARIAT effectively closes the LAA and has acceptable procedural risks with the evolution of the use of the micropuncture needle for pericardial access and the use of colchicine for mitigating the postinflammatory response associated with LAA ligation and pericardial access., (Copyright © 2016 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF